Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia

Prostate

Volumn 54, Issue 4, 2003, Pages 290-298

  Mirtti, Tuomas ^a   Alanen, Kalle ^a   Kallajoki, Markku ^a   Rinne, Ari ^b   Söderström, Karl Ove ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Adenocarcinoma; Cell proliferation; Cystatin A; Cystatin B; Prostate

Indexed keywords

CYCLIN A; CYSTATIN B; CYTOKERATIN; KI 67 ANTIGEN; STEFIN A;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; CELL DIVISION; CYCLIN B; CYSTATINS; HUMANS; KERATINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037369109     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10196     Document Type: Article

References (33)

1. Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentration in biological fluids. J Biol Chem 1986;261(24):11282-11289.
2. Brömme D, Rinne R, Kirshcke H. Tight-binding inhibition of cathepsin S by cystatins. Biomed Biochim Acta 1991;150:631-635.
3. Söderström K-O, Laato M, Wu P, Hopsu-Havu VK, Nurmi M, Rinne A. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma. Int J Cancer 1995;62:1-4.
4. Burton JL, Oakley N, Anderson JB. Recent advances in the histopathology and molecular biology of prostate cancer. BJU International 2000;85:87-94.
5. McLoughlin J, Foster CS, Price P, Williams G, Abel PD. Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Brit J Urol 1993;72:92-97.
6. Oomens EHGM, Van Steenbrugge GJ, Van Der Kwast THH, Schröder FH. Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma. J Urol 1991;145:81-85.
7. Grafia X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-219.
8. Bowen ID, Bowen SM, Jones AH, editors. The cell cycle. In: Mitosis and apoptosis, matters of life and death, first edition, chapter 3, London: Chapman & Hall; 1998. pp 28-59.
9. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996;56:4159-4163.
10. Aaltomaa S, Eskelinen M, Lipponen P. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate 1999;38:175-182.
11. Mirtti T, Kallajoki M, Aaltonen M, Alanen K. Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions. Anal Quant Cytol Histol 2001;23(3):229-237.
12. Mostofi FK. Grading of prostatic carcinoma. Cancer Chemother Rep 1975;59:111-117.
13. Gleason DF, Mellinger GT. Veterans administration cooperative urological research group: Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58-64.
14. Epstein JI. Pathology of adenocarcinoma of the prostate. In: Walsh PC, Retik AB, Vaughan ED Jr., Wein AJ, editors. Campbell urology, seventh edition, volume 3 chapter 81. Philadelphia: WB Saunders Company; 1998. pp 2497-2505.
15. Kominami E, Bando Y, It K, Hizawa K, Katunuma N. Increase of cathepsins B and L and their thiol protease inhibitor in muscle of dystrophic hamsters. Their location in invading phagocytes. J Biochem 1984;96:1841-1848.
16. Ritonja A, Machleidt W, Barrett AJ. Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver. Biochem Biophys Res Comm 1985;131(3):1187-1192.
17. Rinne A. Epidermal SH-protease in human neoplasms and their metastases. Path Res Pract 1980;170:172-179.
18. Davies ME, Barrett AJ. Immunolocalization of human cystatins in neutrophils and lymphocytes. Histochemistry 1984;80:373-377.
19. Rinne A, Järvinen M, Dor NA, Alavaikko M, Jokinen K, Hopsu-Havu VK. Niedermolekulare Cysteinproteinaseinhibitoren in menschlichen Gaumentonsillen. Anat Anz 1986;161:215-230.
20. Rinne R, Järvinen M, Rinne A, Hopsu-Havu VK, Hokkanen E. Purification and some characteristics of a cysteine proteinase inhibitor of the human striated muscle. In: Fossan GO, Gjerde IO, editors. Proceedings of the 25th Scandinavian Congress of Neurology, Supplementum No. 98, Vol. 69. 1984a. pp 220-221.
21. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, De La Chapelle A, Cox DR, Myers RM. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-1734.
22. Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive edges by in situ hybridization. Anat Rec 1993;235:233-240.
23. Algaba F, Epstein JI, Aldape H-C, Farrow GM, Lopez-Beltran A, Maksem J, Orozco RE, Pacelli A, Pisansky TM, Trias I. International consultation on prostatic intraepithelial neoplasia and pathological staging of prostatic carcinoma. Assessment of prostate carcinoma in core needle biopsy-definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996;78(2):376-381.
24. Eide TJ, Järvinen M, Hopsu-Havu VK, Maltau J, Rinne A. Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesion. Acta Histochem 1992;93:241-248.
25. Riccio M, Di Giaimo R, Pianetti S, Palmieri PP, Melli M, Santi S. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp Cell Res 2001;262:84-94.
26. Björklund HV, Johansson TR, Rinne A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J Virol 1997;71(7):5658-5662.
27. Jones B, Roberts PJ, Faubion WA, Kominami E, Gores GJ. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol 1998;275(4 Pt 1):G723-G730.
28. Van Eijk M, Lindhout E, Van Marle J, De Groot C. Follicular dendritic cells secrete cystatin A to block germinal center B lymphocyte apoptosis. In: Regulation of germinal center B cell apoptosis. An academic dissertation 2000. pp 65-79.
29. Friedrich B, Jung K, Lein M, Türk U, Rudolph B, Hampel G, Schnorr D, Loening SA. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999;35:138-144.
30. Ebert E, Werle B, Julke B, Kopitar-Jerala N, Kos J, Lah T, Abrahamson M, Spiess E, Ebert W. Expression of cysteineprotease inhibitors stefin A, stefin B and cystatin C in human lung-tumor tissue. In: Ansorge S, Langner J, editors. Cellular peptidases in immune functions and diseases. New York: Plenum Press; 1997. pp 259-265.
31. Rinne A, Järvinen M, Räsänen O, Hopsu-Havu VK. Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and in infiltrative carcinoma of uterine portio. Exp Pathol 1984b;26:67-70.
32. Shiraishi T, Mori M, Tanaka S, Sugimashi K, Akiyoshi T. Identification of cystatin B in human esophageal carcinoma, using differential displays in which the gene expression is related to lymph-node metastasis. Int J Cancer 1998;79:175-178.
33. Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, Collan Y. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 1998;58(3):432-436.